Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STIM1 | Q13586 | 2/20 | 0.70 |
| ▸ | ORAI1 | Q96D31 | 2/20 | 0.70 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.43 |
| ▸ | NPC1 | O15118 | 3/20 | 0.43 |
| ▸ | RAB9A | P51151 | 3/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.43 |
| ▸ | RELA | Q04206 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 4/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | STAT3 | P40763 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.39 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.39 |
| ▸ | CACNA1I | Q9P0X4 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL758944 | 0.88 | STIM1 (0.76) | STIM1ORAI1ORAI3SMN1; SMN2NPC1 | |
| SCHEMBL758074 | 0.88 | STIM1 (0.70) | STIM1ORAI1ORAI3SMN1; SMN2NPC1 | |
| SCHEMBL755388 | 0.87 | STIM1 (0.73) | STIM1ORAI1ORAI3SMN1; SMN2NPC1 | |
| SCHEMBL3063316 | 0.86 | STIM1 (0.72) | STIM1ORAI1ORAI3SMN1; SMN2NPC1 | |
| SCHEMBL695576 | 0.86 | STIM1 (0.75) | STIM1ORAI1ORAI3SMN1; SMN2NPC1 | |
| SCHEMBL760700 | 0.85 | STIM1 (0.71) | STIM1ORAI1ORAI3SMN1; SMN2NPC1 | |
| SCHEMBL696220 | 0.85 | STIM1 (0.73) | STIM1ORAI1ORAI3SMN1; SMN2NPC1 | |
| SCHEMBL696218 | 0.85 | STIM1 (0.73) | STIM1ORAI1ORAI3SMN1; SMN2NPC1 | |
| SCHEMBL759832 | 0.85 | STIM1 (0.76) | STIM1ORAI1ORAI3SMN1; SMN2NPC1 | |
| SCHEMBL757062 | 0.84 | STIM1 (0.70) | STIM1ORAI1ORAI3SMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120053150-A1 | N-PYRAZOLYL CARBOXAMIDES AS CRAC CHANNEL INIHIBITORS | GLAXO GROUP LIMITED (GB) | 2012-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120053150-A1 | N-PYRAZOLYL CARBOXAMIDES AS CRAC CHANNEL INIHIBITORS | ORAI1, TRPV1, CACNA1E | STIM1 33/4885ORAI1 1/4885ORAI3 25/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.